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The objectives of this study were to gain further insight on Candida genotype
distribution and percentage of clustered isolates between hospitals and to identify
potential clusters involving different hospitals and cities. We aim to genotype Candida
spp. isolates causing candidemia in patients admitted to 16 hospitals in Spain, Italy,
Denmark, and Brazil. Eight hundred and eighty-four isolates (Candida albicans, n =
534; C. parapsilosis, n = 282; and C. tropicalis, n = 68) were genotyped using
species-specific microsatellite markers. CDC3, EF3, HIS3, CAI, CAIII, and CAVI were
used for C. albicans, Ctrm1, Ctrm10, Ctrm12, Ctrm21, Ctrm24, and Ctrm28 for
C. tropicalis, and CP1, CP4a, CP6, and B for C. parapsilosis. Genotypes were
classified as singletons (genotype only found once) or clusters (same genotype infecting
two or more patients). Clusters were defined as intra-hospital (involving patients
admitted to a single hospital), intra-ward (involving patients admitted to the same
hospital ward) or widespread (involving patients admitted to different hospitals). The
percentage of clusters and the proportion of patients involved in clusters among
species, genotypic diversity and distribution of genetic diversity were assessed.
Seven hundred and twenty-three genotypes were detected, 78 (11%) being clusters,
most of which (57.7%; n = 45/78) were intra-hospital clusters including intra-ward
ones (42.2%; n = 19/45). The proportion of clusters was not statistically different
between species, but the percentage of patients in clusters varied among hospitals.
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A number of genotypes (7.2%; 52/723) were widespread (found at different hospitals),
comprising 66.7% (52/78) of clusters, and involved patients at hospitals in the same
city (n = 21) or in different cities (n = 31). Only one C. parapsilosis cluster was
a widespread genotype found in all four countries. Around 11% of C. albicans
and C. parapsilosis isolates causing candidemia are clusters that may result from
patient-to-patient transmission, widespread genotypes commonly found in unrelated
patients, or insufficient microsatellite typing genetic discrimination.
Keywords: Candida, genotyping, microsatellite, cluster, widespread
INTRODUCTION
Among invasive fungal infections, candidemia is the most
common condition in hospitalized patients, representing an
overall incidence rate of 3.88 cases per 100,000 hospital
admissions (Koehler et al., 2019). With Candida albicans on the
top of etiological agents of candidemia, infections with other
species, including Candida parapsilosis, Candida tropicalis, and
Candida glabrata are on the rise (Lamoth et al., 2018; Pappas
et al., 2018). Prevalence of candidemia in high-risk patients such
as critical care patients, oncology, and solid organ transplant
recipients ranges from 2 to 11% (Ostrosky-Zeichner et al., 2007;
Eggimann et al., 2011). Candidemia is associated with high
mortality and high inpatient cost (Wan Ismail et al., 2019).
Attributable mortality ranges from 11 up to 47% (Bilir et al.,
2015).
Candidemia is a nosocomial infection that affects patients
with diverse underlying conditions often caused by the use of
intravascular catheters or translocation of endogenous isolates
from the gut microbiota to the bloodstream (Puig-Asensio
et al., 2014). Exogenous patient-to-patient transmission may
represent an alternative route of infection. Genotyping may
help clarify potential Candida outbreaks and transmission in
hospitalized patients (Escribano et al., 2013, 2018) and clarify if
certain genotypes occur in different patients—namely clusters—
potentially suggesting a common isolate niche (Escribano et al.,
2013; Hammarskjold et al., 2013).
We have previously shown different percentages of clustered
isolates in Spanish and Italian hospitals, suggesting dissimilar
infection control policies (Marcos-Zambrano et al., 2015).
For example, campaigns to reduce the number of catheter-
related infections led to a decrease in the number of clusters
(Escribano et al., 2013, 2018). However, some clusters involved
patients who were either admitted to the same hospital but
without a clear epidemiological link (Escribano et al., 2013,
2018) or admitted to different hospitals that in occasions
were located in different countries (Marcos-Zambrano et al.,
2015). Such “epidemiologically unexplainable” clusters may
indicate a limited discriminatory potential of the typing method
or common widespread clones rather than active patient-to-
patient transmission.
The aim of this study is to genotype Candida spp. isolates
causing candidemia in subjects admitted to 16 hospitals in Spain,
Italy, Denmark, and Brazil with high or very low likelihood of
having been in contact. We provide insight into the genotypes
and percentages of clustered isolates between these hospitals, and
identify clusters involving different hospitals and cities.
MATERIALS AND METHODS
Participating Hospitals and Clinical
Isolates
Sixteen tertiary hospitals located in Spain (Madrid, n = 4;
Valencia, n = 1), Italy (Rome, n = 2), Brazil (São Paulo, n
= 1), and Denmark (three clinical microbiological laboratories
that together served 8 university hospitals in Copenhagen)
participated in this multicentre study. Isolates were collected
from consecutive episodes of candidemia (one isolate per
patient; n = 884) caused by C. albicans (n = 534), C.
parapsilosis (n = 282), or C. tropicalis (n = 68) diagnosed in
patients admitted to the above-mentioned hospitals between
January 2014 and December 2015. Isolates were identified
by MALDI-TOF mass spectrometry or molecular methods
(White et al., 1990; Marklein et al., 2009; De Carolis et al.,
2014; Normand et al., 2019). The number of admissions,
incidence and number of episodes per species during the study
period are shown in Table 1. All participating hospitals have
active taskforces, including microbiologists, infectious disease
specialists and nurses, to monitor and control infections, and
have implemented antimicrobial stewardship programs or, so
called, zero bacteraemia programs. Details of such campaigns at
each hospital were not available.
Genotyping
Isolates were genotyped by species-specific microsatellite
markers. Six markers were used for C. albicans: CDC3, EF3,
HIS3 (Botterel et al., 2001; Sabino et al., 2010), CAI, CAIII,
and CAVI (Sampaio et al., 2005). Markers used for C. tropicalis
were Ctrm1, Ctrm10, Ctrm12, Ctrm21, Ctrm24, and Ctrm28
(Wu et al., 2014), and CP1, CP4a, CP6, and B were used for C.
parapsilosis (Sampaio et al., 2003; Vaz et al., 2011).
Capillary electrophoresis using the ABI 3130xl analyser
(Applied Biosystems-Life Technologies Corporation, Carlsbad,
California, USA) and the GeneScan ROX 500 bp marker
(Applied Biosystems-Life Technologies Corporation, Carlsbad,
California, USA) was performed on the PCR products.
Electropherograms were analyzed with the GeneMapper R© v.4.0
software (Applied Biosystems-Life Technologies Corporation,
California). A control strain from each species was used in each
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TABLE 1 | Epidemiology of candidemia for each participating hospital during the study period.







C. albicans C. parapsilosis C. tropicalis
Brazil
São Paulo 47,176 153 3.06 78/61 31/14 23/19
Denmark**
Rigshospitalet 184,216 122 0.66 58/55 9/7 6/5
Herlev 510,335 108 0.21 55/51 5/3 6/6
Hvidovre 322,090 94 0.29 31/26 3/3 6/5
Spain
Gregorio Marañón 96,890 116 1.17 51/51 32/32 4/4
La Fe 77,833 148 1.19 46/43 64/49 4/4
La Paz 93,044 100 1.08 38/7 36/29 3/2
Puerta de Hierro 51,573 72 1.39 30/26 26/24 2/1
Ramón y Cajal 63,432 85 1.30 36/30 31/29 3/2
Italy
Fondazione Policlinico A. Gemelli 155,851 312 1.99 156/143 74/73 13/13
San Camillo 129,470 340 1.85 45/41 21/19 8/7
Overall 624/534 332/282 78/68
*Mean incidence (cases of candidemia per 1,000 hospital admissions) during 2014–2015.
**Hospitals located at Copenhagen: Bispebjerg, Frederiksberg, Gentofte, Glostrup, Herlev, Hillerød, Hvidovre, Rigshospitalet.
run to ensure size accuracy and avoid run-to-run variations. The
number of base pairs determined the size of alleles in each locus.
Genotype and Cluster Analysis
Allele results were converted to binary data by scoring the
presence or absence of each allele. Data were treated as
categorical, and the genetic relationship between genotypes
was examined by constructing a minimum spanning tree
(BioNumerics version 6.6, Applied Maths, Sint-Martens-Latem,
Belgium). Isolates were considered to have identical genotypes
when they showed the same alleles in all loci. Different
genotypes were codified as follows: CA-X (C. albicans), CP-X (C.
parapsilosis), and CT-X (C. tropicalis), X representing the internal
code of the genotype in our collection. Definitions of singleton
genotypes and clusters are summarized in Table 2.
We compared the percentage of clusters and the proportion
of patients presenting clusters among species and hospitals using
a standard binomial method (95% confidence intervals) (Epidat
3.1 software, Servicio de Información sobre Saúde Pública de la
Dirección Xeral de Saúde Pública de la Consellería de Sanidade,
Xunta de Galicia, Spain).
Genotypic Diversity Analysis
We assessed the following diversity parameters: (a) number
of alleles per locus; (b) observed (direct count) heterozygosity
(Ho), calculated as the number of heterozygous genotypes
over the total number of genotypes analyzed for each locus;
(c) expected heterozygosity (He; calculated as He = 1–Σpi2,
where pi represents the frequency of the ith allele) (Nei, 1973);
Wright’s fixation index [F = 1– (Ho/He)] shows the relationship
between Ho and He and detects heterozygote excess or deficiency
(Lenardon and Nantel, 2012); and (d) the probability of identity
among unrelated individuals [PI= 1–Σpi4 + ΣΣ(2pipj)2],
where pi and pj represent the frequencies of the ith and
jth alleles, respectively and measures the likelihood that two
randomly drawn diploid genotypes will be identical, assuming
the observed allele frequencies and random assortment (Paetkau
et al., 1995). Significant deviations from the Hardy-Weinberg
equilibrium (HWE) at individual loci were tested using the
Markov chain method to determine if a population was clonal.
For the analyses the IDENTITY 1.0 (Wagner et al., 1999)
and ARLEQUIN version 3.01 (Excoffier et al., 2005) programs
were used.
Distribution Analysis of Genetic Diversity
Molecular variance analysis AMOVA) was performed to
determine the distribution of genetic diversity based on the
number of alleles with 10,000 permutations (ARLEQUIN version
3.01) (Excoffier et al., 2005). AMOVA (term and model
inspired by ANOVA but adapted to molecular data) is a
statistical model that allows estimating population differentiation
directly from molecular data. It tests hypotheses on such
differentiations for the molecular algorithm in a single species,
usually biological. Different hierarchical levels—populations—
were established among countries, between singleton genotypes
and clusters (overall and clusters grouped by countries). F
statistics for each hierarchical level were computed. Pairwise
FST values obtained from AMOVA were used to measure the
genetic differentiation between populations and its significance
(P < 0.05) was assessed using a non-parametric permutation
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TABLE 2 | Definitions of singleton genotypes, clusters and clonal complexes of the genotypes used in this study.
Term Definition Possible interpretation
Singleton Genotype found only once
Cluster Same genotype infecting ≥2 patients (with or without
an epidemiological link between the involved patients)
Potentially indicating transmission, widespread clones or genetic
differences not detected by the genotyping method
Intra-hospital cluster Same genotype involving ≥2 patients admitted to the same
hospital within a period of 12 months
Genotype endemic in the hospital that may infect patients not
necessarily during their stay in their admission wards
Intra-ward cluster Intra-hospital cluster involving ≥2 patients admitted to the
same hospital ward within a period of 12 months
Genotype likely indicating the occurrence of patient-to-patient
transmission in a given hospital ward
Widespread cluster Same genotype involving ≥2 patients admitted to different
hospitals
Genotype that usually infects unrelated patients and that barely
indicates patient-to-patient transmission
Intra-hospital and widespread cluster Intra-hospital genotypes found in at least one more patient at
another hospital
Genotype widely distributed usually infecting unrelated patients;
barely indicates patient-to-patient transmission
Clonal complex Group of genotypes showing differences in a single locus Group of clusters genetically related among them, frequently
found and that may have evolved from a common ancestor
approach (Excoffier et al., 2005). Pairwise FST values between
countries were represented by Principal Coordinate Analysis
(PCoA) with the GENEALEX software (Peakall and Smouse,
2012). PCoA allows exploring and visualizing data similarities
or dissimilarities.
RESULTS
We detected 723 genotypes distributed as follows: C. albicans
(n = 453), C. parapsilosis (n = 206), and C. tropicalis (n
= 64); 645 (89.2%) were singletons and 78 (10.8%) were
clusters (Table S1 and Table 3). The proportion of clusters was
not statistically different between species [C. albicans, 10.6%
(48/453), C. parapsilosis, and 12.6% (26/206), and C. tropicalis,
6.2% (4/64)]. The 78 clusters were intra-hospital (n = 26),
widespread (n= 33) or intra-hospital/widespread (n= 19).
Intra-hospital clusters (including intra-hospital/widespread
clusters) comprised around 57% (n = 45/78) of the clusters
(C. albicans, n = 26/48; C. parapsilosis, n = 22/26; and C.
tropicalis, n = 2/4) and were found mostly in Fondazione
Policlinico A. Gemelli (n = 20), La Fe (n = 9), and Ramón y
Cajal (n = 5) hospitals, but were scarcely found in Copenhagen
hospitals (Tables 3, 4, and Figure 1). One hundred and thirty-
four patients presented intra-hospital clusters (C. albicans, n =
62; C. parapsilosis, n = 68; C. tropicalis, n = 4). The proportion
of patients infected by C. parapsilosis clusters in most hospitals
was higher compared with C. albicans (Figure 1A). The 45 intra-
hospital clusters were reduced to 19 intra-ward clusters (C.
albicans, n = 7; C. parapsilosis, n = 10; C. tropicalis, n = 2) that
involved 50 patients (C. albicans, n = 14; C. parapsilosis, n = 32;
C. tropicalis, n = 4), half of which were detected at the medical
wards of Fondazione Policlinico A. Gemelli hospital (Table 5 and
Figure 1B).
A number of genotypes (7.2%; 52/723) were widespread
(C. albicans, n = 32/453; C. parapsilosis, n = 18/206; C.
tropicalis, n = 2/64) and were occasionally found as intra-
hospital clusters at some hospitals (Table 4). Overall, widespread
genotypes comprised 52 of the 78 detected clusters and involved
patients at hospitals in the same (n = 21) or in different cities
(n = 31) (Figure 2); C. tropicalis widespread genotypes (n =
2) were found exclusively in two hospitals in Copenhagen. A
number of widespread C. albicans clusters involved 2–9 patients
each and five clonal complexes were found. Interestingly, at
least one genotype fulfilling the definition of widespread and
intra-hospital cluster was detected in four of the five clonal
complexes (Figure 2A). Clonal complex number 5 included
the highest number of clusters (n = 5) and patients (n =
25). It is worth noting that four out of the five clusters were
widespread and intra-hospital clusters and many of them were
found in Fondazione Policlinico A. Gemelli hospital. As for
C. parapsilosis widespread genotypes, we found some clusters
affecting several patients each (2–12 patients), whereas the
number of clonal complexes was lower than those found for
C. albicans. Again, at least one genotype fulfilling the definition
of widespread and intra-hospital cluster was detected in each
clonal complex (Figure 2B). Clonal complex number 2 was
particularly significant due to the high number of genotypes (n=
4) and patients (n = 28) involved. Three out of the four clusters
were widespread and intra-hospital clusters in different hospitals
(Table 4). Only one C. parapsilosis cluster was a widespread
genotype found in the four countries.
Genetic Diversity and Analysis of
Molecular Variance
Diversity parameters are shown in Table S2. The used
microsatellite marker appeared to be highly discriminatory
since the probability of identity for C. albicans, C. parapsilosis
and C. tropicalis was very low (7.7 × 10−10, 1.2 × 10−6, and 4
× 10−8, respectively). Probability of identity values close to zero
indicates high discriminative power of the used marker. In this
work, total diversity of C. albicans isolates was elevated as shown
by the high number of alleles found (N = 195; mean of 32.5
alleles/marker), the low frequency of null alleles (Na= 0.08), and
the observed and expected heterozygosity (Ho = 0.67 and He =
0.84, respectively). Contrarily, the diversity of C. parapsilosis and
C. tropicalis isolates was lower.
Wright’s index (F) indicates a deficiency (positive values) or
excess (negative values) heterozygosity. Heterozygote deficiency
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was observed in the three species (C. albicans [F = 0.19],
C. parapsilosis [F = 0.43], and C. tropicalis [F = 0.38]).
Allele frequencies of all loci differed significantly (P < 0.05)
from what was expected in a population in Hardy–Weinberg
equilibrium for the three species. This suggests clonal expansion
due to migrations between countries/hospitals, although we
should not exclude other factors including genetic drift, natural
selection, sexual selection, mutation, gene flow, meiotic drive,
genetic hitchhiking, population bottleneck, founder effect and
inbreeding. Diversity parameters were assessed by country with
no significant differences (Table S2).
The AMOVA analysis per species showed that most estimated
variations were found within the strains of a given population;
however, pooling isolates by geographical regions showed that a
small but significant proportion of variations may be attributed
to differences among countries (3% C. albicans, 2.22% C.
parapsilosis, and 5.63% C. tropicalis, P < 0.001) (Table 5).
Likewise, this analysis revealed differences between singleton
genotypes and clusters (1.5% C. albicans, 1% C. parapsilosis, and
5.96% C. tropicalis, P < 0.05) (Table 6).
FST measures the genetic differentiation between populations
with lower values indicating scarce differentiation. C. tropicalis
showed the highest differentiation among countries (FST = 0.05,
P<0.001) and between singletons and clusters (FST = 0.05, P <
0.05). Principal coordinate representation of FST values for the
three species shows low but significant differentiation between
countries, with isolates from Spain and Italy being more closely
related (Figure 3).
DISCUSSION
The genotyping analysis performed in this study reveals
widespread Candida genotypes causing candidemia at distant
geographic areas.
Previous studies suggest that Candida genotyping is useful to
study hospital infection outbreaks under the umbrella of clinical
suspicion (Diekema et al., 1997; Kuhn et al., 2004; Lasheras et al.,
2007). Conversely, blindly genotyping of consecutive candidemia
isolates unveiled lurking genotypes actively causing infections
at some wards (Escribano et al., 2013) where implementation
of campaigns to prevent catheter-related infections had a
positive impact (Escribano et al., 2018). Moreover, differences
in the number of clusters among hospitals may indicate
dissimilar infection control policies with potential room for
improvement (Marcos-Zambrano et al., 2015). Results from
our previous abovementioned studies led us to conclude that
the higher the incidence of candidemia in a given period of
time, the higher the percentage of clusters. Additionally, some
clusters involve epidemiologically linked patients (same ward
within 12 months) suggesting either nosocomial transmission
between patients or outbreaks, whereas other clusters involve
patients who are apparently epidemiologically unrelated. The
presence of these unexplainable clusters led us to coin the term
“widespread genotypes,” making reference to patients admitted
to different hospitals. Here, we enlarge the number of isolates and
participating hospitals located at various geographic regions that
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TABLE 4 | Intra-hospital clusters indicating the species, number of patients involved in each cluster and affected hospitals.
Species Cluster code Hospital Patients involved Species Cluster code Hospital Patients involved
C. albicans CA-789 São Paulo 2 C. parapsilosis CP-039* H. Fondazione A. Gemelli 2
CA-830 2 CP-355 São Paulo 4
CA-039 Gregorio Marañón 2 CP-056* Gregorio Marañón 2
CA-406 2 CP-023* Gregorio Marañón 2
CA-305 La Fe 2 La Fe 2
CA-432 2 Fondazione A. Gemelli 5
CA-502 2 Ramón y Cajal 2
CA-515* 2 CP-031* La Fe 8
CA-035* H. Fondazione A. Gemelli 2 CP-063 3
CA-048* 4 CP-161* 2
CA-051* 3 CP-117* La Fe 3
CA-059* 2 La Paz 3
CA-071 3 CP-065 La Paz 2
CA-107 2 CP-094* 2
CA-364* 3 CP-196* Puerta de Hierro 3
CA-632 3 Ramón y Cajal 3
CA-633 3 CP-199* H. Fondazione A. Gemelli 2
CA-670 3 CP-271 4
CA-701 2 CP-272 3
CA-736* 2 CP-282 4
CA-762 2 CP-240 Ramón y Cajal 3
CA-565* Rigshospitalet 4 CP-242 4
CA-571 2 C. tropicalis CT-074 H. Fondazione A. Gemelli 2
CA-597* 2 CT-118 São Paulo 2
CA-331* Ramón y Cajal 2
CA-741 San Camilo 2
*Intra-hospital and widespread clusters.
Cluster code in bold indicates intra-ward cluster and the hospital at which they were found; genotypes CP-023 and CP-065 are widespread clusters and also intra-ward clusters in
Fondazione A. Policlinico Gemelli and Puerta de Hierro hospitals, respectively.
would resemble differences in hospital management and variable
candidemia incidence.
The prevalence of all three Candida species is consistent
with previously reported candidemia epidemiology (Colombo
et al., 2017). Even though most patients in this study were
infected by singleton genotypes (89%), clusters were detected
in around 11% of them. Notably, the proportion of patients
with clusters and incidence of candidemia differed between
hospitals, with the lowest incidence found in Denmark and
the highest in Brazil, which may indicate distinct campaigns
to control hospital infections, adherence to infection control
guidelines, type of population at risk of acquiring candidemia
in each hospital, and/or differences in patient length of stay
at the health care center. The result of candidemia incidence
does not necessarily match with the number/proportion of
clusters. C. tropicalis and C. albicans are, respectively, the
species with the lowest and highest number of clusters, and
C. parapsilosis (n = 17) presenting an intermediate number.
When intra-ward clusters are analyzed, the number of C. albicans
clusters outnumbers those of C. parapsilosis (n = 7 vs. n =
10). This indicates that C. parapsilosis clusters resist a more
stringent definition of cluster and may show patient-to-patient
transmission. Candidemia-related outbreaks by C. parapsilosis
are relatively common (Diab-Elschahawi et al., 2012; Singh et al.,
2019; Toth et al., 2019).
The genetic definition of cluster may be misleading
when trying to disentangle hospital patient-to-patient
transmission, particularly in apparently unrelated patients.
When epidemiological information is considered, clusters
may be tagged differently. The most restrictive definition of
intra-ward cluster requires that the affected patients be admitted
to the same hospital ward thereby increasing the likelihood
of patient-to-patient transmission. Contrarily, intra-hospital
clusters may indicate the presence of an endemic genotype in
the hospital that infects patients admitted to different wards. An
intra-hospital cluster not meeting the definition of intra-ward
cluster is an enigma and may result from a lack of microsatellite
discriminatory power. However, there are other possible
explanations. First, given the retrospective nature of most
studies, patients may have acquired the infection not in the niche
of the genotype, as shown by Clostridioides difficile (Tarrant et al.,
2018). Second, some genotypes may be more frequent and better
adapted than others, persisting in hospital facilities for a longer
time. Finally, we speculate that the higher the number of patients
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FIGURE 1 | Distribution of intra-hospital clusters (A), intra-ward clusters (B), and percentage of patients involved in clusters among participating hospitals.
colonized by certain genotypes, the higher the chances to find
the genotypes causing candidemia. Furthermore, the presence of
widespread genotypes is even more difficult to interpret and we
cannot rule out that certain clones may have spread worldwide.
Some genotypes can be found in different countries, as reported
with Candida glabrata (Al-Yasiri et al., 2016; Adams et al., 2018)
or more recently on C. auris (de Groot et al., 2020).
C. auris was first detected in 2009 and since then different
local clades have been identified. These clades are thought
to be diverging locally over time. Coexistence of several
geographic clades have identified at hospitals admitting patients
from separate endemic areas of C. auris infections (Borman
et al., 2017; de Groot et al., 2020). With this scenario, similar
clones infecting different patients may not be an indication
of patient-to-patient transmission but a previous colonization
by the specific clade even before the admission of the patient
to the hospital. Migration from endemic areas may facilitate
clone dissemination (Al-Yasiri et al., 2016; Carrete et al., 2018;
de Groot et al., 2020). As C. albicans and C. parapsilosis
have had more time to evolve than C. auris, the number
of genotypes found for these two species is higher than
for C. auris. Widespread genotypes may resemble what is
seen for the different C. auris linages. That is, widespread
genotypes resemble clonal genotypes with longer time to spread
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Hospital Admission ward Date of blood
culture collection
C. albicans CA-039 2 Gregorio Marañón Post-surgical ICU Oct 2014
Dec 2014
CA-406 2 Gregorio Marañón Neonatology Sep 2015
Sep 2015
CA-432 2 La Fe Hematology Sep 2014
Oct 2014
CA-048 2 Fundazione Policlinico A. Gemelli Medical ward Sep 2015
Nov 2015
CA-059 2 Fundazione Policlinico A. Gemelli Medical ward Apr 2014
Jun 2014
CA-071 2 Fundazione Policlinico A. Gemelli Medical ward Feb 2014
Feb 2014
CA-364 2 Fundazione Policlinico A. Gemelli Medical ward May 2014
May 2014
C. parapsilosis CP-023 3 Fundazione Policlinico A. Gemelli Medical ward Jan 2015
Jul 2015
Aug 2015






CP-065 2 La Paz Post-surgical ICU Jul 2015
Dec 2015
CP-196 2 Puerta de Hierro ICU Nov 2015
Nov 2015
CP-199 2 Fundazione Policlinico A. Gemelli Medical ward Dec 2014
Dec 2014




CP-272 3 Fundazione Policlinico A. Gemelli Pneumology Sep 2014
Nov 2014
Apr 2015




CP-240 2 Ramón y Cajal Hematology Oct 2015
Nov 2015




C. tropicalis CT-074 2 Fundazione Policlinico A. Gemelli Medical ward Jun 2015
Jun 2015
CT-118 2 São Paulo ICU Aug 2014
Aug 2014
worldwide by colonizingmany individuals (de Groot et al., 2020),
demonstrated the presence of identical C. auris genotypes in
different countries.
The lack of geographic-specific genotypes shown by the
AMOVA analysis points to a similar genetic background and
a common clonal ancestor with an effective spread pattern.
C. albicans and C. parapsilosis populations are not in Hardy-
Weinberg equilibrium, suggesting that the genetic background
in these species is mostly clonal or followed by selection pressure
by interaction with the host or the environment (Sabino et al.,
2010). Other markers, such as multilocus sequence typing, have
previously suggested a clonal origin of C. albicans isolates
(Tavanti et al., 2005).
There is no neat genotype geographic-specific distribution.
However, genotypes from Italy and Spain are more similar
among them in comparison to the others. This observation,
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FIGURE 2 | Minimum spanning tree showing the C. albicans (A) and C. parapsilosis (B) widespread genotypes. Circles represent different genotypes and circle size
the number of isolates belonging to the same genotype. Colors indicate the country from which the isolate was obtained. Connecting lines between the circles show
profile similarities; solid bold lines indicate differences in only 1 marker (clonal complexes are shadowed in gray), the solid line indicates differences in 2 markers, long
dashes in dashed line indicate differences in 3 markers, and short dashes indicate differences in 4 or more markers. Genotypes in bold indicate widespread genotypes
and intra-hospital clusters. Denmark (red), Spain (purple), Italy (yellow), and Brazil (green).
which in turn may suggest a more frequent dissemination
of genotypes between two neighboring countries, may be a
consequence of the large number of isolates from the these
two countries.
Our study has some limitations: First, we cannot rule out that
some clusters may be a consequence of insufficient microsatellite
typing discriminatory power—although diversity parameters do
not support this—due to events of genomic recombination or
partial chromosomal aneuploidy (Hirakawa et al., 2015). Whole
genome sequencing of isolates of the largest clonal complexes are
justified. Second, we missed some isolates causing candidemia
during the study period, which prevented us from confirming
all potential clusters. Third, we had an asymmetric collection of
isolates as some countries contributed with more isolates than
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TABLE 6 | Analysis of molecular variance (AMOVA)* partitioning genetic diversity within and among countries, and within and between singletons and clusters.








Among countries 3.01 0.03 2.22 0.02 5.63 0.05
Within countries 96.99 97.78 94.37
Between singletons/clusters 1.50 0.01 1.04 0.01 5.96 0.05
Within singletons/clusters 98.50 98.96 94.04
*AMOVA values measure the genetic differentiation between populations. Numbers shown in bold indicate statistically significant differences (P < 0.05).
FIGURE 3 | Principal coordinates analysis showing the genetic differentiation
of C. albicans (A), C. parapsilosis (B), and C. tropicalis (C) among isolates
grouped by country. Symbols represent the variability found within each
country; symbols in the same square are more likely to be related among them
rather than to those located in other squares.
others. Fourth, we did not genotype environmental isolates that
may be prevalent in the hospitals or assessed their frequency
in those wards of hospitalization before the study period.
Fifth, culture-negative cases of invasive candidiasis may lead
to underestimate the number of clusters. Finally, clinical data
was not collected, preventing us to decipher if clusters could be
associated with specific clinical conditions or if they represented
patient-to-patient transmission.
In conclusion, we show that around 11% of C. albicans and C.
parapsilosis isolates causing candidemia are clusters originated
from either patient-to-patient transmissions, widespread
genotypes commonly found in unrelated patients, or lack of
microsatellite genetic discrimination. Further studies using
whole genome sequencing will help decipher the usefulness of
microsatellite markers to conduct epidemiological studies and
redefine the definition of cluster.
DATA AVAILABILITY STATEMENT
All relevant data is contained within the article. The original
contributions presented in the study are included in the
article/Supplementary Files, further inquiries can be directed to
the corresponding authors.
ETHICS STATEMENT
This study was approved by the Ethics Committee of Hospital
Gregorio Marañón (CEIC-A1; study no. 108/16).
AUTHOR’S NOTE
This study was partially presented at the 27th European Congress
of Clinical Microbiology and Infectious Diseases in Vienna
(P1437 and P0947), Austria, April 2017 and at the 28th European
Congress of Clinical Microbiology and Infectious Diseases in
Madrid (EP863), Spain, April 2018.
AUTHOR CONTRIBUTIONS
PE and JG designed the study. AG contributed to the
development and methodology. MA, RC, EC, JG, AG, EP, RH,
BO, MS, JP, BP, AR-G, GP, DD, AC, CS-C, ER, PM, JG-R, and
PE collected the data. JG and PE carried out the data analysis
and investigation. MA, RC, PE, and JG wrote all sections of the
manuscript. MA, RC, EC, JG, AG, EP, RH, BO, MS, JP, BP, AR-G,
GP, DD, AC, CS-C, ER, PM, JG, and PE revised the manuscript.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 May 2020 | Volume 10 | Article 166
Guinea et al. Candida Widespread Genotypes Causing Candidemia
STUDY GROUP
The following participants are part of the project’s study
group: Jesus Guinea, Ana Gómez, Elena Reigadas, Patricia
Muñoz, Carlos Sánchez-Carrillo, and Pilar Escribano (Hospital
Gregorio Marañón, Madrid, Spain). Maiken C. Arendrup,
Rasmus Hare (Statens Serum Institut, Copenhagen, Denmark).
Rafael Cantón, Elia Gómez (Hospital Ramón y Cajal, Madrid,
Spain). Emilia Cantón, Javier Pemán and Alba Cecilia Ruiz-
Gaitán (Hospital La Fe, Valencia, Spain). Maurizio Sanguinetti,
Brunella Posteraro and Antonietta Vella (Fondazione Policlinico
Universitario A; Gemelli IRCCS, Rome, Italy). Gabriella Parisi
(Azienda Ospedaliera San Camillo-Forlanini, Rome). Julio
García-Rodríguez (Hospital La Paz, Madrid, Spain). Beatriz
Orden (Hospital Puerta de Hierro, Madrid, Spain). Arnaldo
Lopes Colombo, Daniel Archimedes Da Matta (Universidade
Federal de São Paulo, São Paulo, Brazil).
FUNDING
This work was supported by grants CP15/00115 and PI16/01012
from the Fondo de Investigación Sanitaria (FIS. Instituto de Salud
Carlos III; Plan Nacional de I+D+I 2013–2016). This study
was co-funded by the European Regional Development Fund
(FEDER) A way of making Europe. In Brazil, this work was
supported by a grant 2017/02203-7 from Fundação de Amparo
a Pesquisa-São Paulo (FAPESP). The funders had no role in the
study design, data collection, analysis, decision to publish, or
preparation/content of the manuscript. PE (MSI15/00115) and
JG (MSII15/00006) are recipients of a Miguel Servet contract
supported by the FIS.
ACKNOWLEDGMENTS
The authors are grateful to Ciencia Traducida for editing and
proofreading assistance.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fcimb.
2020.00166/full#supplementary-material
Table S1 | Genotype code, type of genotype, and microsatellite allelic
composition in base pairs.
Table S2 | Diversity parameters calculated for each country as mean values.
aObserved and expected heterozygosity ranged from 0 (no heterozygosity) to
1(highest heterozygosity). bWright’s index indicates a deficiency of heterozygosity
(positive values) or excess heterozygosity (negative values). cThe probability of
identity indicates the likelihood of finding two identical genotypes after randomly
selecting two isolates.
REFERENCES
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., et al.
(2018). Candida auris in healthcare facilities, New York, USA, 2013-2017.
Emerging Infect. Dis. 24, 1816–1824. doi: 10.3201/eid2410.180649
Al-Yasiri, M. H., Normand, A. C., L’Ollivier, C., Lachaud, L., Bourgeois,
N., Rebaudet, S., et al. (2016). Opportunistic fungal pathogen Candida
glabrata circulates between humans and yellow-legged gulls. Sci. Rep. 6:36157.
doi: 10.1038/srep36157
Bilir, S. P., Ferrufino, C. P., Pfaller, M. A., and Munakata, J. (2015). The economic
impact of rapid Candida species identification by T2Candida among high-risk
patients. Future Microbiol. 10, 1133–1144. doi: 10.2217/fmb.15.29
Borman, A. M., Szekely, A., and Johnson, E. M. (2017). Isolates of the emerging
pathogen Candida auris present in the UK have several geographic origins.
Med. Mycol. 55, 563–567. doi: 10.1093/mmy/myw147
Botterel, F., Desterke, C., Costa, C., and Bretagne, S. (2001). Analysis of
microsatellite markers of Candida albicans used for rapid typing. J. Clin.
Microbiol. 39, 4076–4081. doi: 10.1128/JCM.39.11.4076-4081.2001
Carrete, L., Ksiezopolska, E., Pegueroles, C., Gomez-Molero, E., Saus, E., Iraola-
Guzman, S., et al. (2018). Patterns of genomic variation in the opportunistic
pathogen Candida glabrata suggest the existence of mating and a secondary
association with humans. Curr. Biol. 28, 15–27. doi: 10.1016/j.cub.2017.
11.027
Colombo, A. L., de Almeida Junior, J. N., Slavin, M. A., Chen, S. C., and Sorrell, T.
C. (2017). Candida and invasive mould diseases in non-neutropenic critically
ill patients and patients with haematological cancer. Lancet Infect. Dis. 17,
e344–e356. doi: 10.1016/S1473-3099(17)30304-3
De Carolis, E., Vella, A., Vaccaro, L., Torelli, R., Posteraro, P., Ricciardi, W.,
et al. (2014). Development and validation of an in-house database for matrix-
assisted laser desorption ionization-time of flight mass spectrometry-based
yeast identification using a fast protein extraction procedure. J. Clin. Microbiol.
52, 1453–1458. doi: 10.1128/JCM.03355-13
de Groot, T., Puts, Y., Berrio, I., Chowdhary, A., and Meis, J. F. (2020).
Development of C. auris short tandem repeat typing and its application to a
global collection of isolates.MBio 11:e02971-19. doi: 10.1128/mBio.02971-19
Diab-Elschahawi, M., Forstner, C., Hagen, F., Meis, J. F., Lassnig, A. M., Presterl,
E., et al. (2012). Microsatellite genotyping clarified conspicuous accumulation
of Candida parapsilosis at a cardiothoracic surgery intensive care unit. J. Clin.
Microbiol. 50, 3422–3426. doi: 10.1128/jcm.01179-12
Diekema, D. J., Messer, S. A., Hollis, R. J., Wenzel, R. P., and Pfaller, M. A.
(1997). An outbreak of Candida parapsilosis prosthetic valve endocarditis.
Diagn. Microbiol. Infect. Dis. 29, 147–153. doi: 10.1016/s0732-8893(97)81804-4
Eggimann, P., Bille, J., and Marchetti, O. (2011). Diagnosis of invasive candidiasis
in the ICU. Ann. Intensive Care 1:37. doi: 10.1186/2110-5820-1-37
Escribano, P., Rodriguez-Creixems, M., Sánchez-Carrillo, C., Muñoz, P., Bouza,
E., and Guinea, J. (2013). Endemic genotypes of Candida albicans causing
fungemia are frequent in the hospital. J. Clin. Microbiol. 51, 2118–2123.
doi: 10.1128/jcm.00516-13
Escribano, P., Sánchez-Carrillo, C., Muñoz, P., Bouza, E., and Guinea, J.
(2018). Reduction in percentage of clusters of Candida albicans and Candida
parapsilosis causing candidemia in a general hospital in Madrid, Spain. J. Clin.
Microbiol. 56, e00574–e00518. doi: 10.1128/JCM.00574-18
Excoffier, L., Guillaume, L., and Schneider, G. (2005). Arlequin (version 3.0):
an integrated software package for population genetics data analysis. Evol.
Bioinform. 1, 47–50.
Hammarskjold, F., Mernelius, S., Andersson, R. E., Berg, S., Hanberger, H.,
Lofgren, S., et al. (2013). Possible transmission of Candida albicans on an
intensive care unit: genotype and temporal cluster analyses. J. Hosp. Infect. 85,
60–65. doi: 10.1016/j.jhin.2013.06.002
Hirakawa, M. P., Martinez, D. A., Sakthikumar, S., Anderson, M. Z., Berlin,
A., Gujja, S., et al. (2015). Genetic and phenotypic intra-species variation
in Candida albicans. Genome Res. 25, 413–425. doi: 10.1101/gr.1746
23.114
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M., Bohlius,
J., et al. (2019). Morbidity and mortality of candidaemia in Europe:
an epidemiologic meta-analysis. Clin. Microbiol. Infect. 25, 1200–1212.
doi: 10.1016/j.cmi.2019.04.024
Kuhn, D. M., Mikherjee, P. K., Clark, T. A., Pujol, C., Chandra, J., Hajjeh, R.
A., et al. (2004). Candida parapsilosis characterization in an outbreak setting.
Emerging Infect. Dis. 10, 1074–1081. doi: 10.3201/eid1006.030873
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 May 2020 | Volume 10 | Article 166
Guinea et al. Candida Widespread Genotypes Causing Candidemia
Lamoth, F., Lockhart, S. R., Berkow, E. L., and Calandra, T. (2018). Changes in
the landscape of invasive candidiasis. J. Antimicrob. Chemother. 73(Suppl. 1),
i4–i13. doi: 10.1093/jac/dkx444
Lasheras, A., Rogues, A. M., Peyrere, S., Boulard, G., Bebear, C. M., Gachie, J. P.,
et al. (2007). Candida albicans outbreak in a neurosurgical intensive care unit.
J. Hosp. Infect. 65, 181–182.
Lenardon, M. D., and Nantel, A. (2012). Rapid detection of aneuploidy following
the generation of mutants in Candida albicans. Methods Mol. Biol. 845, 41–49.
doi: 10.1007/978-1-61779-539-8_3
Marcos-Zambrano, L. J., Escribano, P., Sanguinetti, M., Gomez, G., d. l. P. E., De
Carolis, E., et al. (2015). Clusters of patients with candidaemia due to genotypes
of Candida albicans and Candida parapsilosis: differences in frequency between
hospitals. Clin. Microbiol. Infect. 21, 677–683. doi: 10.1016/j.cmi.2015.03.007
Marklein, G., Josten, M., Klanke, U., Muller, E., Horre, R., Maier, T., et al. (2009).
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for
fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47,
2912–2917. doi: 10.1128/JCM.00389-09
Nei, M. (1973). Analysis of gene diversity in subdivide populations. Proc. Natl.
Acad. Sci. U.S.A. 70, 3321–3323.
Normand, A. C., Gabriel, F., Riat, A., Cassagne, C., Bourgeois, N., Huguenin,
A., et al. (2019). Optimization of MALDI-ToF mass spectrometry for yeast
identification: a multicenter study. Med. Mycol. doi: 10.1093/mmy/myz098.
[Epub ahead of print].
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V.,
et al. (2007). Multicenter retrospective development and validation of a clinical
prediction rule for nosocomial invasive candidiasis in the intensive care setting.
Eur. J. Clin. Microbiol. Infect. Dis. 26, 271–276. doi: 10.1007/s10096-007-
0270-z
Paetkau, D., Calvert,W., Stirling, I., and Strobeck, C. (1995). Microsatellite analysis
of population structure in canadian polar bears.Mol. Ecol. 4, 347–354.
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., and
Kullberg, B. J. (2018). Invasive candidiasis. Nat. Rev. Dis. Primers. 4:18026.
doi: 10.1038/nrdp.2018.26
Peakall, R., and Smouse, P. E. (2012). GenAlEx 6.5: genetic analysis in
Excel. population genetic software for teaching and research–an update.
Bioinformatics 28, 2537–2539. doi: 10.1093/bioinformatics/bts460
Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J. M.,
Zaragoza, R., et al. (2014). Epidemiology and predictive factors for early and late
mortality in Candida bloodstream infections: a population-based surveillance
in Spain. Clin. Microbiol. Infect. 20, O245–O254. doi: 10.1111/1469-0691.
12380
Sabino, R., Sampaio, P., Rosado, L., Stevens, D. A., Clemons, K. V., and Pais, C.
(2010). New polymorphic microsatellite markers able to distinguish among
Candida parapsilosis sensu stricto isolates. J. Clin. Microbiol. 48, 1677–1682.
doi: 10.1128/JCM.02151-09
Sampaio, P., Gusmao, L., Alves, C., Pina-Vaz, C., Amorim, A., and Pais, C. (2003).
Highly polymorphic microsatellite for identification of Candida albicans
strains. J. Clin. Microbiol. 41, 552–557. doi: 10.1128/jcm.41.2.552-557.2003
Sampaio, P., Gusmao, L., Correia, A., Alves, C., Rodrigues, A. G., Pina-Vaz, C.,
et al. (2005). New microsatellite multiplex PCR for Candida albicans strain
typing reveals microevolutionary changes. J. Clin. Microbiol. 43, 3869–3876.
doi: 10.1128/JCM.43.8.3869-3876.2005
Singh, A., Singh, P. K., de Groot, T., Kumar, A., Mathur, P., Tarai, B., et al. (2019).
Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates
in a multicentre laboratory-based surveillance study in India. J. Antimicrob.
Chemother. 74, 1260–1268. doi: 10.1093/jac/dkz029
Tarrant, J., Jenkins, R. O., and Laird, K. T. (2018). From ward to washer:
The survival of Clostridium difficile spores on hospital bed sheets through
a commercial UK NHS healthcare laundry process. Infect. Control Hosp.
Epidemiol. 39, 1406–1411. doi: 10.1017/ice.2018.255
Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A., Maiden, M. C., and
Odds, F. C. (2005). Population structure and properties of Candida albicans,
as determined by multilocus sequence typing. J. Clin. Microbiol. 43, 5601–5613.
doi: 10.1128/JCM.43.11.5601-5613.2005
Toth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M.,
Nosanchuk, J. D., et al. (2019). Candida parapsilosis: from genes to the
bedside. Clin. Microbiol. Rev. 32, e00111–e00118. doi: 10.1128/CMR.00
111-18
Vaz, C., Sampaio, P., Clemons, K. V., Huang, Y. C., Stevens, D. A., and Pais,
C. (2011). Microsatellite multilocus genotyping clarifies the relationship of
Candida parapsilosis strains involved in a neonatal intensive care unit outbreak.
Diagn. Microbiol. Infect. Dis. 71, 159–162. doi: 10.1016/j.diagmicrobio.2011.
05.014
Wagner, H. W., Sefc, K. M., and Wagner, H. W. (1999). IDENTITY 1.0. Centre of
Applied Genetics. Vienna: University of Agricultural Sciences.
Wan Ismail, W. N. A., Jasmi, N., Khan, T. M., Hong, Y. H., and Neoh, C.
F. (2019). The economic burden of candidemia and invasive candidiasis: a
systematic review. Value Health Reg. Issues 21, 53–58. doi: 10.1016/j.vhri.2019.
07.002
White, T., Bruns, T., Lee, S., and Taylor, J. (1990). “Amplification and direct
sequencing of fungal ribosomal RNA genes for phylogenetics,” in PCR protocols:
a guide to methods and applications, eds M. A. Innis, D. H. Gefland, J.J. Sninsky,
and T.J. White (San Diego, CA: Academic Press) 315–322.
Wu, Y., Zhou, H. J., Che, J., Li, W. G., Bian, F. N., Yu, S. B., et al. (2014). Multilocus
microsatellite markers for molecular typing of Candida tropicalis isolates. BMC
Microbiol. 14:245. doi: 10.1186/s12866-014-0245-z
Conflict of Interest: JG has received funds for participating at educational
activities organized on behalf of Astellas, Gilead, MSD, Scynexis, and Biotoscana-
United Medical; he has also received research funds from FIS, Gilead, Scynexis,
and Cidara, outside the submitted work. AC received educational grants from
Biotoscana-United Medical, MSD, Pfizer and research grant from Astellas and
Pfizer. MA reports personal fees from Astellas, Basilea, Gilead, MSD, Pfizer,
T2Biosystems, and Novartis, other from Astellas, Basilea, Gilead, T2Biosystems,
F2G, Novabiotics and Amplyx outside the submitted work.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
The reviewer JM declared past co-authorship with one of the authors AC to
the handling editor.
Copyright © 2020 Guinea, Arendrup, Cantón, Cantón, García-Rodríguez, Gómez,
de la Pedrosa, Hare, Orden, Sanguinetti, Pemán, Posteraro, Ruiz-Gaitán, Parisi,
Da Matta, Colombo, Sánchez-Carrillo, Reigadas, Muñoz and Escribano. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12 May 2020 | Volume 10 | Article 166
